:max_bytes(150000):strip_icc():format(webp)/Blood-In-Lab-GettyImages-73329514-8f6d6e24438049eab4fb5bd13d59954c.jpg "CAR T-Cell Therapy Helps Lupus Patients Enter Remission In Small Study")
The therapy, typically used to treat blood cancer, has so far induced remission in six patients in Germany.
By
An immunotherapy used to treat blood cancer also shows promise as a treatment for lupus, new research shows.
The news comes from a small study, published last week in Nature Medicine, in which German researchers treated five patients with systemic lupus erythematosus (SLE) with autologous chimeric antigen receptor (CAR) T-cell therapy.
The treatment, given in a single dose, induced remission in all five patients within three months—and they remained in remission for an average of eight months after treatment, according to the study authors. The first person to receive CAR-T treatment as part of the study was still in remission more than a year later.
